Listed

ProMIS Neurosciences Inc.

PMNNasdaqCIK 1374339HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$12.3m, Q2 FY2026
Net income−$11.7m, Q2 FY2026
ProMIS Neurosciences Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m1.1Research and development, Q3 FY2023, three months to 2023-09-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figure2.2Research and development, Q4 FY2023, three months to 2023-12-31$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001558370-25-004068. Derived: 12-month figure less the 9-month figure.Report this figure2.1Research and development, Q1 FY2024, three months to 2024-03-31$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure1.6Research and development, Q2 FY2024, three months to 2024-06-30$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure2.6Research and development, Q3 FY2024, three months to 2024-09-30$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure4.3Research and development, Q4 FY2024, three months to 2024-12-31$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001104659-26-034554. Derived: 12-month figure less the 9-month figure.Report this figure5.5Research and development, Q1 FY2025, three months to 2025-03-31$5.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure8.7Research and development, Q2 FY2025, three months to 2025-06-30$8.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure9.8Research and development, Q3 FY2025, three months to 2025-09-30$9.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure9.4Research and development, Q4 FY2025, three months to 2025-12-31$9.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001104659-26-034554. Derived: 12-month figure less the 9-month figure.Report this figure7.0Research and development, Q1 FY2026, three months to 2026-03-31$7.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure9.5Research and development, Q2 FY2026, three months to 2026-06-30$9.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure
Operating income$m(2.5)Operating income, Q3 FY2023, three months to 2023-09-30−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figure(3.9)Operating income, Q4 FY2023, three months to 2023-12-31−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001558370-25-004068. Derived: 12-month figure less the 9-month figure.Report this figure(3.7)Operating income, Q1 FY2024, three months to 2024-03-31−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure(2.7)Operating income, Q2 FY2024, three months to 2024-06-30−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure(4.4)Operating income, Q3 FY2024, three months to 2024-09-30−$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure(6.0)Operating income, Q4 FY2024, three months to 2024-12-31−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034554. Derived: 12-month figure less the 9-month figure.Report this figure(7.5)Operating income, Q1 FY2025, three months to 2025-03-31−$7.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure(10.2)Operating income, Q2 FY2025, three months to 2025-06-30−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure(11.8)Operating income, Q3 FY2025, three months to 2025-09-30−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure(10.8)Operating income, Q4 FY2025, three months to 2025-12-31−$10.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034554. Derived: 12-month figure less the 9-month figure.Report this figure(8.6)Operating income, Q1 FY2026, three months to 2026-03-31−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure(12.3)Operating income, Q2 FY2026, three months to 2026-06-30−$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$75.4k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figurenot reported0.1Interest expense, Q1 FY2024, three months to 2024-03-31$76.8k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure(0.0)Interest expense, Q2 FY2024, three months to 2024-06-30−$1. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-08, accession 0001558370-24-011476. Derived: 6-month figure less the 3-month figure.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$1. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015634. Derived: 9-month figure less the 6-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(2.4)Net income, Q3 FY2023, three months to 2023-09-30−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figure(3.6)Net income, Q4 FY2023, three months to 2023-12-31−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001558370-25-004068. Derived: 12-month figure less the 9-month figure.Report this figure(3.6)Net income, Q1 FY2024, three months to 2024-03-31−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure(2.6)Net income, Q2 FY2024, three months to 2024-06-30−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure9.3Net income, Q3 FY2024, three months to 2024-09-30$9.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure(0.2)Net income, Q4 FY2024, three months to 2024-12-31−$238.2k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034554. Derived: 12-month figure less the 9-month figure.Report this figure(7.3)Net income, Q1 FY2025, three months to 2025-03-31−$7.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure(10.1)Net income, Q2 FY2025, three months to 2025-06-30−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure(11.6)Net income, Q3 FY2025, three months to 2025-09-30−$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure(10.7)Net income, Q4 FY2025, three months to 2025-12-31−$10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034554. Derived: 12-month figure less the 9-month figure.Report this figure(8.2)Net income, Q1 FY2026, three months to 2026-03-31−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure(11.7)Net income, Q2 FY2026, three months to 2026-06-30−$11.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure
Diluted EPS$ per share(0.19)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figurenot reported(0.19)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure(0.13)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure0.31Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figurenot reported(5.27)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$5.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure(7.26)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$7.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure(0.24)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figurenot reported(1.26)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure(1.28)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure
Basic EPS$ per share(0.19)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figurenot reported(0.19)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure(0.13)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure0.31Basic EPS, Q3 FY2024, three months to 2024-09-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figurenot reported(5.27)Basic EPS, Q1 FY2025, three months to 2025-03-31−$5.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure(7.26)Basic EPS, Q2 FY2025, three months to 2025-06-30−$7.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure(0.24)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figurenot reported(1.26)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure(1.28)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure

Balance sheet

Cash and equivalents$53.4m, Q2 FY2026
Long-term debt$0, FY2023
Shareholders' equity$49.4m, Q2 FY2026
ProMIS Neurosciences Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m16.9Cash and equivalents, Q3 FY2023, at 2023-09-30$16.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001558370-23-019048.Report this figure12.6Cash and equivalents, FY2023, at 2023-12-31$12.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001558370-25-004068.Report this figure2.5Cash and equivalents, Q1 FY2024, at 2024-03-31$2.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001558370-24-008145.Report this figure1.0Cash and equivalents, Q2 FY2024, at 2024-06-30$992.5k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001558370-24-011476.Report this figure21.5Cash and equivalents, Q3 FY2024, at 2024-09-30$21.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figure13.3Cash and equivalents, FY2024, at 2024-12-31$13.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-25, accession 0001104659-26-034554.Report this figure8.4Cash and equivalents, Q1 FY2025, at 2025-03-31$8.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure4.5Cash and equivalents, Q2 FY2025, at 2025-06-30$4.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure15.4Cash and equivalents, Q3 FY2025, at 2025-09-30$15.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure6.1Cash and equivalents, FY2025, at 2025-12-31$6.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure63.8Cash and equivalents, Q1 FY2026, at 2026-03-31$63.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure53.4Cash and equivalents, Q2 FY2026, at 2026-06-30$53.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure
Current assets$m17.9Current assets, Q3 FY2023, at 2023-09-30$17.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019048.Report this figure13.6Current assets, FY2023, at 2023-12-31$13.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001558370-25-004068.Report this figure3.5Current assets, Q1 FY2024, at 2024-03-31$3.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008145.Report this figure1.4Current assets, Q2 FY2024, at 2024-06-30$1.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011476.Report this figure24.5Current assets, Q3 FY2024, at 2024-09-30$24.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figure18.9Current assets, FY2024, at 2024-12-31$18.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-25, accession 0001104659-26-034554.Report this figure13.6Current assets, Q1 FY2025, at 2025-03-31$13.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure9.5Current assets, Q2 FY2025, at 2025-06-30$9.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure21.5Current assets, Q3 FY2025, at 2025-09-30$21.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure9.2Current assets, FY2025, at 2025-12-31$9.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure65.6Current assets, Q1 FY2026, at 2026-03-31$65.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure56.7Current assets, Q2 FY2026, at 2026-06-30$56.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure
Total assets$m17.9Total assets, Q3 FY2023, at 2023-09-30$17.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001558370-23-019048.Report this figure13.6Total assets, FY2023, at 2023-12-31$13.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001558370-25-004068.Report this figure3.5Total assets, Q1 FY2024, at 2024-03-31$3.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001558370-24-008145.Report this figure1.4Total assets, Q2 FY2024, at 2024-06-30$1.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001558370-24-011476.Report this figure24.5Total assets, Q3 FY2024, at 2024-09-30$24.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figure18.9Total assets, FY2024, at 2024-12-31$18.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-25, accession 0001104659-26-034554.Report this figure13.6Total assets, Q1 FY2025, at 2025-03-31$13.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure9.5Total assets, Q2 FY2025, at 2025-06-30$9.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure21.5Total assets, Q3 FY2025, at 2025-09-30$21.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure9.2Total assets, FY2025, at 2025-12-31$9.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure67.4Total assets, Q1 FY2026, at 2026-03-31$67.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure56.7Total assets, Q2 FY2026, at 2026-06-30$56.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure
Current liabilities$m9.9Current liabilities, Q3 FY2023, at 2023-09-30$9.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019048.Report this figure9.3Current liabilities, FY2023, at 2023-12-31$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001558370-25-004068.Report this figure2.6Current liabilities, Q1 FY2024, at 2024-03-31$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008145.Report this figure3.2Current liabilities, Q2 FY2024, at 2024-06-30$3.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011476.Report this figure2.6Current liabilities, Q3 FY2024, at 2024-09-30$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figure2.2Current liabilities, FY2024, at 2024-12-31$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-25, accession 0001104659-26-034554.Report this figure4.1Current liabilities, Q1 FY2025, at 2025-03-31$4.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure9.8Current liabilities, Q2 FY2025, at 2025-06-30$9.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure12.2Current liabilities, Q3 FY2025, at 2025-09-30$12.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure10.4Current liabilities, FY2025, at 2025-12-31$10.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure6.6Current liabilities, Q1 FY2026, at 2026-03-31$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure7.2Current liabilities, Q2 FY2026, at 2026-06-30$7.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure
Total liabilities$m11.1Total liabilities, Q3 FY2023, at 2023-09-30$11.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001558370-23-019048.Report this figure9.9Total liabilities, FY2023, at 2023-12-31$9.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001558370-25-004068.Report this figure3.5Total liabilities, Q1 FY2024, at 2024-03-31$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001558370-24-008145.Report this figure3.7Total liabilities, Q2 FY2024, at 2024-06-30$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001558370-24-011476.Report this figure17.2Total liabilities, Q3 FY2024, at 2024-09-30$17.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figure2.4Total liabilities, FY2024, at 2024-12-31$2.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-25, accession 0001104659-26-034554.Report this figure4.2Total liabilities, Q1 FY2025, at 2025-03-31$4.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure9.9Total liabilities, Q2 FY2025, at 2025-06-30$9.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure12.3Total liabilities, Q3 FY2025, at 2025-09-30$12.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure10.4Total liabilities, FY2025, at 2025-12-31$10.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure6.7Total liabilities, Q1 FY2026, at 2026-03-31$6.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure7.3Total liabilities, Q2 FY2026, at 2026-06-30$7.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure
Long-term debt$mnot reported0.0Long-term debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-04-01, accession 0001558370-24-004532.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m6.8Shareholders' equity, Q3 FY2023, at 2023-09-30$6.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figure3.8Shareholders' equity, FY2023, at 2023-12-31$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-25, accession 0001104659-26-034554.Report this figure0.1Shareholders' equity, Q1 FY2024, at 2024-03-31$77.1k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure(2.3)Shareholders' equity, Q2 FY2024, at 2024-06-30−$2.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure7.3Shareholders' equity, Q3 FY2024, at 2024-09-30$7.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure16.5Shareholders' equity, FY2024, at 2024-12-31$16.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure9.5Shareholders' equity, Q1 FY2025, at 2025-03-31$9.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure(0.4)Shareholders' equity, Q2 FY2025, at 2025-06-30−$382.6k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure9.2Shareholders' equity, Q3 FY2025, at 2025-09-30$9.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure(1.3)Shareholders' equity, FY2025, at 2025-12-31−$1.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure60.7Shareholders' equity, Q1 FY2026, at 2026-03-31$60.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure49.4Shareholders' equity, Q2 FY2026, at 2026-06-30$49.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure

Cash flow

Operating cash flow−$10.4m, Q2 FY2026
ProMIS Neurosciences Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(2.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001558370-24-015634. Derived: 9-month figure less the 6-month figure.Report this figure(3.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001558370-25-004068. Derived: 12-month figure less the 9-month figure.Report this figure(10.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure(1.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001558370-25-011299. Derived: 6-month figure less the 3-month figure.Report this figure(6.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001104659-25-109719. Derived: 9-month figure less the 6-month figure.Report this figure(8.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001104659-26-034554. Derived: 12-month figure less the 9-month figure.Report this figure(4.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure(3.9)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001104659-26-095895. Derived: 6-month figure less the 3-month figure.Report this figure(10.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$10.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001104659-25-109719. Derived: 9-month figure less the 6-month figure.Report this figure(9.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001104659-26-034554. Derived: 12-month figure less the 9-month figure.Report this figure(12.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$12.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure(10.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$10.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001104659-26-095895. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)9.14m, Q2 FY2026
ProMIS Neurosciences Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares7.2Diluted shares (weighted), Q3 FY2022, three months to 2022-09-307,195,529 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001558370-23-019048.Report this figure8.6Diluted shares (weighted), Q1 FY2023, three months to 2023-03-318,579,284 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001558370-24-008145.Report this figure8.6Diluted shares (weighted), Q2 FY2023, three months to 2023-06-308,579,284 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001558370-24-011476.Report this figure12.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3012,370,830 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001558370-24-015634.Report this figure19.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3119,533,976 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001558370-25-007255.Report this figure19.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3019,770,739 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001558370-25-011299.Report this figure30.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3030,067,095 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure1.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-311,394,048 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure1.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,394,048 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure48.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3048,833,799 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001104659-25-109719.Report this figure6.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-316,527,779 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001104659-26-059035.Report this figure9.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-309,142,366 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure

Shares outstanding: 8.97mShares outstanding, period not labelled, at 2026-08-138,967,693 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001104659-26-095895.Report this figure at Aug 13, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.